• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Invivoscribe Technologies - Articles and news items

Novartis’ acute myeloid leukaemia drug granted FDA priority review

Industry news / 18 November 2016 / Niamh Louise Marriott, Digital Content Producer

The FDA granted priority review to the PKC412 (midostaurin) new drug application as treatment for acute myeloid leukaemia…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +